CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer

CITED1 as a marker of favourable outcome in anti-endocrine treated, estrogen-receptor positive, lymph-node negative breast cancer

Abstract Objective To investigate CITED1 as a potential biomarker of anti-endocrine response and breast cancer recurrence, given its previously determined role in mediating estrogen-dependant transcription. The study is a continuation of earlier work establishing the role of CITED1 in mammary gland...

Full description

Bibliographic Details
Main Authors: Malin Dahlgren, Barbara Lettiero, Hina Dalal, Kira Mårtensson, Alexander Gaber, Björn Nodin, Sofia K. Gruvberger-Saal, Lao H. Saal, Jillian Howlin
Format: Article
Language:English
Published: BMC 2023-06-01
Series:BMC Research Notes
Subjects:
Tamoxifen
CITED1
ERα
Breast cancer
Anti-endocrine
Aromatase inhibitor
Online Access:https://doi.org/10.1186/s13104-023-06376-1

Internet

https://doi.org/10.1186/s13104-023-06376-1

Similar Items